More recently, a subgroup of patients with NSCLC was found to carry TP53 and ataxia telangiectasia‐mutated (ATM) co‐mutations, which were associated with an increased TMB and a better response to ICIs.21 This evidence concerns the gene TP53 and non-small cell lung carcinoma.